Yousif Capital Management’s Fulgent Genetics FLGT Stock Holding History

Yousif Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,050	Closed	-$291K	–	1992
2023 Q4	$291K	Sell	10,050 -70	-0.7%	-$1.87K	﹤0.01%	1765
2023 Q3	$271K	Sell	10,120 -460	-4%	-$15.7K	﹤0.01%	1750
2023 Q2	$392K	Sell	10,580 -635	-6%	-$22.1K	﹤0.01%	1603
2023 Q1	$350K	Sell	11,215 -1,445	-11%	-$46.5K	﹤0.01%	1641
2022 Q4	$377K	Sell	12,660 -6,013	-32%	-$215K	﹤0.01%	1613
2022 Q3	$712K	Buy	18,673 +58	+0.3%	+$2.91K	0.01%	1361
2022 Q2	$1.01M	Sell	18,615 -1,190	-6%	-$65.4K	0.01%	1229
2022 Q1	$1.24M	Buy	19,805 +540	+3%	+$35.6K	0.01%	1259
2021 Q4	$1.94M	Buy	+19,265	New	+$1.69M	0.02%	990

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Yousif Capital Management's FLGT Position: Q1 2024 in Review

Yousif Capital Management sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 10,050 shares — an estimated $291K sold.

Yousif Capital Management first reported a position in FLGT in Q4 2021 and held it in 9 quarters. The position peaked at $1.94M in Q4 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

Yousif Capital Management reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
Yousif Capital Management sold 10,050 Fulgent Genetics shares in Q1 2024, an estimated $291K.
Yousif Capital Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 9 quarters.
Yousif Capital Management's Fulgent Genetics position peaked at $1.94M in Q4 2021.
180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Yousif Capital Management's 13F filing for Q1 2024, filed 26 Apr 2024.